Search research articles
Contact Us
Filters
Showing results (191-200 of 249) with videos related to
Page
of 25
Sort By:
Annals of Hepatology
|
August 15, 2024
Evaluation of four chatbots in autoimmune liver disease: A comparative analysis
Jimmy Daza, Lucas Soares Bezerra, Laura Santamaría, et al.
Journal of Clinical Medicine
|
April 3, 2021
Real-World Clinical Management of Patients with Primary Biliary Cholangitis-A Retrospective Multicenter Study from Germany
Anne-Christin Beatrice Wilde, Charlotte Lieb, Elise Leicht, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 30, 2023
Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based study
Najib Ben Khaled, Bernhard Mörtl, Dominik Beier, et al.
Zeitschrift Fur Gastroenterologie
|
March 24, 2026
Life-style factors of patients with metabolic dysfunction-associated steatotic liver disease - Data from the German SLD-Registry
Andreas Geier, Martin A Kabelitz, Monika Rau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 6, 2023
Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based study
Najib Ben Khaled, Bernhard Mörtl, Dominik Beier, et al.
Hepatology (Baltimore, Md.)
|
March 13, 2024
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series
Christopher Dietz-Fricke, Elisabetta Degasperi, Mathias Jachs, et al.
JHEP Reports : Innovation in Hepatology
|
July 18, 2025
PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feeding
Lina Jegodzinski, Lorena Rudolph, Darko Castven, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 18, 2025
Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis D
Toni Herta, Christopher Dietz-Fricke, Münevver Demir, et al.
Cells
|
December 23, 2022
Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation
Marta Alonso-Peña, Ricardo Espinosa-Escudero, Heike M Hermanns, et al.
The Lancet. Gastroenterology & Hepatology
|
July 27, 2019
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial
Stefan Traussnigg, Jörn M Schattenberg, Münevver Demir, et al.
Page
of 25
Search research articles
Search
Showing results (191-200 of 249) with videos related to
Sort By:
Page
of 25
Annals of Hepatology
|
August 15, 2024
Evaluation of four chatbots in autoimmune liver disease: A comparative analysis
Jimmy Daza, Lucas Soares Bezerra, Laura Santamaría, et al.
Journal of Clinical Medicine
|
April 3, 2021
Real-World Clinical Management of Patients with Primary Biliary Cholangitis-A Retrospective Multicenter Study from Germany
Anne-Christin Beatrice Wilde, Charlotte Lieb, Elise Leicht, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 30, 2023
Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based study
Najib Ben Khaled, Bernhard Mörtl, Dominik Beier, et al.
Zeitschrift Fur Gastroenterologie
|
March 24, 2026
Life-style factors of patients with metabolic dysfunction-associated steatotic liver disease - Data from the German SLD-Registry
Andreas Geier, Martin A Kabelitz, Monika Rau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 6, 2023
Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based study
Najib Ben Khaled, Bernhard Mörtl, Dominik Beier, et al.
Hepatology (Baltimore, Md.)
|
March 13, 2024
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series
Christopher Dietz-Fricke, Elisabetta Degasperi, Mathias Jachs, et al.
JHEP Reports : Innovation in Hepatology
|
July 18, 2025
PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feeding
Lina Jegodzinski, Lorena Rudolph, Darko Castven, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 18, 2025
Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis D
Toni Herta, Christopher Dietz-Fricke, Münevver Demir, et al.
Cells
|
December 23, 2022
Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation
Marta Alonso-Peña, Ricardo Espinosa-Escudero, Heike M Hermanns, et al.
The Lancet. Gastroenterology & Hepatology
|
July 27, 2019
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial
Stefan Traussnigg, Jörn M Schattenberg, Münevver Demir, et al.
Page
of 25